Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 141 studies with search of: | "Lapatinib" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Ductal Carcinoma In Situ (DCIS) Lapatinib Trial
|
||||
2 | Active, not recruiting |
Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer
|
||||
3 | Recruiting |
Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer
|
||||
4 | Completed |
Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus
|
||||
5 | Recruiting |
Neoadjuvant GW572016 to Treat Breast Cancer
|
||||
6 | Completed |
Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer
|
||||
7 | Not yet recruiting |
A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors
|
||||
8 | Active, not recruiting |
Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer
|
||||
9 | Active, not recruiting |
A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer
|
||||
10 | Active, not recruiting |
Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer
|
||||
11 | Recruiting |
LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
|
||||
12 | Active, not recruiting |
Capecitabine (XELODA) With Or Without Lapatinib(GW572016)For Women With Refractory Advanced or Metastatic Breast Cancer
|
||||
13 | Recruiting |
Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC
|
||||
14 | Recruiting |
Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2
|
||||
15 | Not yet recruiting |
A Phase II Study to Evaluate the Efficacy of Lapatinib in the Blood of Women With Breast Cancer
|
||||
16 | Recruiting |
Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study
|
||||
17 | Recruiting |
Phase I Study of Ixabepilone + Lapatinib +/- Capecitabine to Treat HER2 Positive Locally Advanced or Metastatic Breast Cancer
|
||||
18 | Recruiting |
Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer
|
||||
19 | Recruiting |
Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-Line Therapy in HER2/Neu-Positive Breast Cancer
|
||||
20 | Recruiting |
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
|
Previous Page | Studies Shown (1-20) | Next (21-40) |